Saccharomyces cerevisiae β-carbonic anhydrase: Inhibition and activation studies

Current Pharmaceutical Design

Volumn 16, Issue 29, 2010, Pages 3327-3336

  Isik, Semra ^a   Guler, Ozen Ozensoy ^a   Kockar, Feray ^a   Aydin, Meltem ^a   Arslan, Oktay ^a   Supuran, Claudiu T ^b  

^a BALIKESIR UNIVERSITY   (Turkey)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Activator; Amine; Amino acid; Anion inhibitor; Beta class enzyme; Carbonic anhydrase; Saccharomyces cerevisiae; Sulfamate; Sulfonamide; Yeast

Indexed keywords

4 (2 AMINO PYRIMIDIN 4 YL) BENZENESULFONAMIDE; ACETAZOLAMIDE; ADRENALIN; ANION; ANTIFUNGAL AGENT; BENZENEARSONIC ACID; BENZENESULFONAMIDE DERIVATIVE; BENZOLAMIDE; BETA CARBONIC ANHYDRASE; BRINZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CARBOXYL GROUP; CELECOXIB; DORZOLAMIDE; ETHOXZOLAMIDE; INDISULAM; METHAZOLAMIDE; PIPERAZINE DERIVATIVE; SACCHARIN; SACCHAROMYCES CEREVISIAE PROTEIN; SULFANILAMIDE; SULFONAMIDE; SULPIRIDE; SULTIAME; TOPIRAMATE; UNCLASSIFIED DRUG; VALDECOXIB; ZONISAMIDE;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BIOCATALYST; CANDIDA; CARBOXYLATION; COMPETITIVE INHIBITION; CRYPTOCOCCUS NEOFORMANS; CRYSTAL STRUCTURE; DECARBOXYLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HYDRATION; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION;

AMINES; AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ANIONS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; ENZYME ACTIVATION; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78649850033     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793429878     Document Type: Article

References (34)

1. Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 Genes. Science 1996; 274: 546-67.
2. Cleves AE, Cooper DN, Barondes SH, Kelly RB. A new pathway for protein export in S. cerevisiae. J Cell Biol 1996; 133: 1017-26.
3. Götz R, Gnann A, Zimmermann FK. Deletion of the carbonic anhydrase-like gene NCE103 of the yeast S. cerevisiae causes an oxygen-sensitive growth defect. Yeast 1999; 15: 855-64.
4. Amoroso G, Morell-Avrahov L, Muller D, Klug K, Sultemeyer D. The gene NCE103 (YNL036w) from S. cerevisiae encodes a functional carbonic anhydrase and its transcription is regulated by the concentration of inorganic carbon in the medium. Mol Microbiol 2005; 56: 549-58.
5. Aguilera J, Van Dijken JP, De Winde JH, Pronk JT. Carbonic anhydrase (Nce103p): an essential biosynthetic enzyme for growth of S. cerevisiae at atmospheric carbon dioxide pressure. Biochem J 2005; 391: 311-6.
6. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7:168-81.
7. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase inhibitors. Inhibition of the β-class enzyme from the yeast S. cerevisiae with anions. Bioorg Med Chem Lett 2008; 18: 6327-31
8. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase inhibitors. Inhibition of the β-class enzyme from the yeast S. cerevisiae with sulfonamides and sulfamates Bioorg Med Chem 2009; 17: 1158-63.
9. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase activators: Activation of the β-carbonic anhydrase Nce103 from the yeast S. cerevisiae with amines and amino acids. Bioorg Med Chem Lett 2009; 19: 1662-5
10. Elleuche S, Pöggeler S. Carbonic anhydrases in fungi. Microbiology 2010; 156: 23-9.
11. Hall RA, Mühlschlegel FA. Fungal and nematode carbonic anhydrases. In: Supuran CT, Winum JY, Eds. Drug design of zincenzyme inhibitors: functional, structural, and disease applications. Hoboken: Wiley 2009; pp. 301-22.
12. Innocenti A, Mühlschlegel FA, Hall RA, Steegborn C, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens candida albicans and cryptococcus neoformans with simple anions. Bioorg Med Chem Lett 2008; 18: 5066-70.
13. Innocenti A, Hall RA, Schlicker C, Mühlschlegel FA, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates. Bioorg Med Chem 2009; 17: 2654-7.
14. Innocenti A, Hall RA, Schlicker C, et al. Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal β- carbonic anhydrase from candida albicans with sulfonamides. Bioorg Med Chem 2009; 17: 4503-9.
15. Klengel T, Liang WJ, Chaloupka J, et al. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol 2005; 15: 2021-6.
16. Bahn YS, Cox GM, Perfect JR, Heitman J. Carbonic anhydrase and CO2 sensing during cryptococcus neoformans growth, differentiation, and virulence. Curr Biol 2005; 15: 2013-20.
17. Mogensen EG, Janbon G, Chaloupka J, et al. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot Cell 2006; 5: 103-11.
18. Bahn YS, Mühlschlegel FA. CO2 sensing in fungi and beyond. Curr Opin Microbiol 2006; 9: 572-8.
19. Rowlett RS. Structure and catalytic mechanism of the β-carbonic anhydrases. Biochim Biophys Acta 2010; 1804: 362-73.
20. Nishimori I, Onishi S, Takeuchi H, Supuran CT. The α- and β- classes carbonic anhydrases from helicobacter pylori as novel drug targets. Curr Pharm Des 2008; 14: 622-30.
21. Zimmerman SA, Ferry JG, Supuran CT. Inhibition of the archaeal β-Class (Cab) and γ-Class (Cam) carbonic anhydrases. Curr Top Med Chem 2007; 7: 901-8.
22. Supuran CT, Scozzafava A. Matrix metalloproteinases (MMPs). In: Smith HJ, Simons C, Eds. Proteinase and peptidase inhibition: recent potential targets for drug development. London & New York: Taylor & Francis 2002; pp. 35-61.
23. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007; 15: 4336-50
24. Mastrolorenzo A, Rusconi S, Scozzafava A, Barbaro G, Supuran CT. Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors. Curr Med Chem 2007; 14: 2734-48.
25. 2-sensing carbonic anhydrase Can2 from the pathogenic fungus cryptococcus neoformans. J Mol Biol 2009; 385: 1207-20.
26. Temperini C, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII and XIV with L- and D- phenylalanine and crystallographic analysis of their adducts with isozyme II: sterospecific recognition within the active site of an enzyme and its consequences for the drug design. J Med Chem 2006; 49: 3019-27.
27. Temperini C, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators. Kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I - XIV. Bioorg Med Chem 2008; 16: 8373-8.
28. Innocenti A, Zimmerman SA, Scozzafava A, Ferry JG, Supuran CT. Carbonic anhydrase activators. Activation of the archaeal β- class (Cab) and γ-class (Cam) carbonic anhydrases with amino acids and amines. Bioorg Med Chem Lett 2008; 18: 6194-8
29. Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006; 12: 7057-66
30. Temperini C, Scozzafava A, Supuran CT. Drug design studies of carbonic anhydrase activators. In: Supuran CT, Winum JY, Eds. Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken: Wiley 2009; pp. 473-86.
31. Covarrubias AS, Bergfors T, Jones TA, Högbom M. Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis. J Biol Chem 2006; 281: 4993-9.
32. Maertens JA, Boogaerts MA. Fungal cell wall inhibitors: emphasis on clinical aspects. Curr Pharm Des 2000; 6(2): 225-239.
33. Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008; 14(7): 641-648.
34. Supuran CT. Carbonic anhydrases--an overview. Curr Pharm Des 2008; 14(7): 603-614.